Skip to content

Funding success for the Maridulu Budyari Gumal - SPHERE Cancer Clinical Academic Group

The NSW Government through the Cancer Institute NSW has awarded SPHERE's Professor Geoff Delaney a $7M Translational Cancer Research Capacity Building Grant to build capacity and education across the SPHERE Cancer Clinical Academic Group. Commencing on 1 July, the 5 year program will enhance the volume of cancer research the CAG produces, but also to accelerate research translation; ensure succession planning by enhancing career development opportunities; and continue to stimulate high-quality, multidisciplinary, multi-institutional, innovative, impactful research.

The Cancer Institute NSW Translational Cancer Research Capacity Building Grant aims to provide the NHMRC Advanced Health and Research Translation Centres with the funds to strengthen cancer research capacity in NSW and foster a collaborative culture of research to drive improvements in cancer care and outcomes for people living with cancer across the state.

Led by Professor Geoff Delaney, a Radiation Oncologist and Director of Cancer Services for South West Sydney Local Health District, the $7M program will  support the engine room of successful translational research by recruiting high calibre, talented early and middle career researchers (ECRs, MCRs) and PhD students across a broad range of scientific and professional backgrounds; collaborate with all translational research groups in NSW and build on the education, career development and networking that exists between them; and provide crucial administrative support to maintain the CAG’s collaborative research programmes, stimulate new ideas and co-ordinate recruitment, training and competitive funding opportunities.

Professor Delaney has over 30 years of clinical and research experience and over 20 years of leadership experience in complex, collaborative and strategic projects.

The funding will build upon the 'Big Ideas' initiative already established by the Cancer CAG and provide the areas of focus with dedicated support to further research translation and education. The Cancer CAG will build upon the strong foundations laid by the collaborations between the former Cancer Institute NSW Translational Cancer Research Centres (CONCERT and TCRN) and brings together over 1200 cancer professionals across the South East and South West of Sydney.  

Cancer Institute NSW announcment:

Recording of the SPHERE Adaptive and Platform Trials Information Session

A link to the recording of the Adaptive & Platform Trials Information Session held on the 16th November 2021 by the Maridulu Budyari Gumal (SPHERE) Clinical Trials Platform.

Congratulations to Ms Ainslie Cahill AM

Maridulu Budyari Gumal - Sydney Partnership for Health Education, Research and Enterprise (SPHERE) is delighted to announce that Ms Ainslie Cahill, SPHERE’s Leader in Consumer and Community Involvement and Engagement, has been appointed as a member of the Council for the National Health and Medical Research Council (NHMRC). We congratulate Ainslie on her appointment which is clear recognition of her contribution to, and expertise in, Consumer and Community Involvement in research.

Join Us

Maridulu Budyari Gumal, the Sydney Partnership for Health, Education, Research and Enterprise (SPHERE) has partnered with Join Us to save lives and improve the health of all Australians and we need your help!